Avita Medical (RCEL)
AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Austral...
- Open
- 11.040
- High
- 11.040
- Low
- 10.610
- Prev. Close
- 11.020
- Volume
- 194.68K
- Turnover
- 2.10M
- Avg Price
- 10.801
- Bid/Ask Ratio
- --
- Amplitude
- 3.90%
- 52wk High
- 11.390
- Volume Ratio
- 1.12
- Turnover Ratio
- 0.64%
Avita Medical Analyst Rating
View moreForecast & Rating
Sep 17, 2026Price forecast
$12.2513.05%
Forecast & RatingStrong buy
3analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Quartr · Sep 16 at 06:21 PM
RCEL: Operational discipline and portfolio expansion drive growth, with cash flow breakeven targeted for Q4 2026
- PUBT · Sep 2 at 08:11 PM
Avita Medical management attends Morgan Stanley Global Healthcare Conference fireside chat
- Market Beat · Aug 19 at 12:02 PM
Avita Medical PermeaDerm Study Shows 70% Cost Reduction vs. Allograft
- StockTitan · Aug 18 at 03:45 AM
AVITA Medical Announces Positive PermeaDerm® Study Results Demonstrating 70% Economic Advantage over Allograft and Comparable Clinical Outcomes | RCEL Stock News
